Dr. Allal Boutajangout graduated from the Free University of Brussels (ULB-Erasme Hospital), School of Medicine (PhD in Neuropathology). He completed his Postdoctoral training at New York University School of Medicine. He is a Res Associate Professor of Neurology, Neuroscience & Physiology. Co-Director of the Center for Cognitive Neurology Biomarker Core; and Chief of the Lab of Neurodegeneration and Drug Discovery Program, at NYU Grossman SOM. He received several prestigious awards, grant from Alzheimer Association, pilot NIH grant, and Co-Investigator in several NIH grants. He has published more than 58 papers in reputed journals and serves as a reviewer for many scientific journals.